CALR and neoplasm: Upon internalization by tumor cells, CuX-P induced cuproptosis through the liberation of DSF/Cu2+, while also triggering elevated CRT expression and HMGB1 release, thereby facilitating the recognition and activation of tumor-associated antigens by dendritic cells.